Axsome Therapeutics(AXSM) - 2025 Q2 - Earnings Call Transcript
Axsome Therapeutics (AXSM) Q2 2025 Earnings Call August 04, 2025 08:00 AM ET Company ParticipantsDarren Opland - Director - Corporate CommunicationsHerriot Tabuteau - Founder, Chairman & CEONick Pizzie - CFOAri Maizel - CCOSean Laaman - Executive DirectorPoorna Kannan - Biotech Equity Research AssociatePete Stavropoulos - Director - Biotech Equity ResearchAshwani Verma - Executive Director - SMID Biotech & BiopharmaRaghuram Selvaraju - MD - Healthcare Equity ResearchMarc Goodman - Senior MD - NeuroscienceCe ...